Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City
The sequential trial compares recovery and mHealth engagement outcomes among Black participants who participated in the mHealth intervention uMAT-R or uMAT-R + enhanced community engagement. The mHealth intervention seeks to support people in various stages of recovery who are also seeking other forms of substance use treatment. Participants are recruited from community-based substance use treatment facilities and recovery services. Participants must be adults who have or are currently using opioids and/or…
Conditions studied
Opioid Use, Stimulant Use, Depression and Anxiety Symptoms
About this study
The sequential trial compares recovery and mHealth engagement outcomes among Black participants who participated in the mHealth intervention uMAT-R or uMAT-R + enhanced community engagement. The mHealth intervention seeks to support people in various stages of recovery who are also seeking other forms of substance use treatment. Participants are recruited from community-based substance use treatment facilities and recovery services. Participants must be adults who have or are currently using opioids and/or stimulants.
Interventions
- Behavioral: uMAT-R + enhanced community engagement — uMAT-R + enhanced community engagement involves an optimized community engagement strategy employed by the intervention team. This involves in-person interactions with eligible participants and recruitment sites.
- Behavioral: Original uMAT-R supplementary mHealth recovery intervention — uMAT-R supplementary mHealth recovery intervention is the original intervention without optimization of the community engagement approach.
Primary outcomes
- Abstinence/ Changes in Substance Use (Time 0 (Baseline) and Time 1 (One Month))
- Opioid use/ Stimulant use disorder symptoms (Time 0 (Baseline) and Time 1 (One Month))
Eligibility information
Study locations
- Washington University School of Medicine, St Louis, Missouri 63110 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-21.